Lion Point Capital, LP - Stock Holdings in 13F Filings (SEC)
Updated on March 15, 2026.
Based on 13F Filings filed with the SEC on February 17, 2026, for the 2025 Q4 period, Lion Point Capital, LP held in its portfolio 39 assets valued at $19,323,534 (i.e. $19.32M).
The most valuable assets in the portfolio included: MILESTONE PHARMACEUTICALS IN ($1.53M), PRAXIS PRECISION MEDICINES I ($1.31M), and MOONLAKE IMMUNOTHERAPEUTICS ($889.65K).
The chart below shows the top 10 valuable assets, and the table below shows the top 39 valuable assets.
You can see similar for other investment managers.
Related Topics: SEC Topic List.
Data Source: SEC.
Lion Point Capital, LP - Stock Holdings in 13F Filings (SEC)
Items per page:
25
0 of 0
| Name of Issuer | No. of Shares | Value ($) | Class |
|---|---|---|---|
| MILESTONE PHARMACEUTICALS IN | 755000 | 1525100 | COM |
| PRAXIS PRECISION MEDICINES I | 4450 | 1311593 | COM NEW |
| MOONLAKE IMMUNOTHERAPEUTICS | 67500 | 889650 | CLASS A ORD |
| FENNEC PHARMACEUTICALS INC | 112434 | 865742 | COM |
| JASPER THERAPEUTICS INC | 465000 | 850950 | COM NEW |
| BENITEC BIOPHARMA INC | 62000 | 835140 | COM NEW |
| ROYALTY PHARMA PLC | 21400 | 826896 | SHS CLASS A |
| GERON CORP | 578000 | 762960 | COM |
| SYNDAX PHARMACEUTICALS INC | 36000 | 756360 | COM |
| ARDELYX INC | 128650 | 750030 | COM |
| CUE BIOPHARMA INC | 2202854 | 672752 | COM |
| DISC MEDICINE INC | 8100 | 643221 | COM |
| SAREPTA THERAPEUTICS INC | 28500 | 613320 | COM |
| BIOHAVEN LTD | 51700 | 583693 | COM |
| HUMACYTE INC | 500000 | 480250 | COM |
| KURA ONCOLOGY INC | 46000 | 477940 | COM |
| SERES THERAPEUTICS INC | 31570 | 469762 | COM NEW |
| COMPASS PATHWAYS PLC | 58000 | 400200 | SPONSORED ADS |
| DAY ONE BIOPHARMACEUTICALS I | 42000 | 391440 | COM |
| REGENXBIO INC | 26600 | 383040 | COM |
| BRIDGEBIO PHARMA INC | 5000 | 382450 | COM |
| MINERALYS THERAPEUTICS INC | 10500 | 381045 | COM |
| VENTYX BIOSCIENCES INC | 41500 | 374745 | COM |
| LANTHEUS HLDGS INC | 5500 | 366025 | COM |
| DYNE THERAPEUTICS INC | 18000 | 352080 | COM |
| UNIQURE NV | 14700 | 351771 | SHS |
| PACIRA PHARMACEUTICALS INC | 13500 | 349380 | COM |
| VIATRIS INC | 27700 | 344865 | COM |
| AZENTA INC | 9700 | 322622 | COM |
| ROCKET PHARMACEUTICALS INC | 86000 | 301860 | COM |
| JANUX THERAPEUTICS INC | 19000 | 262200 | COM |
| EDGEWISE THERAPEUTICS INC | 9100 | 225817 | COM |
| INNOVIVA INC | 8200 | 163918 | COM |
| ARCUTIS BIOTHERAPEUTICS INC | 5250 | 152460 | COM |
| INNATE PHARMA S A | 81151 | 142014 | SPONSORED ADS |
| MINERVA NEUROSCIENCES INC | 35000 | 140700 | COM NEW |
| GH RESEARCH PLC | 10200 | 129540 | ORDINARY SHARES |
| SPRUCE BIOSCIENCES INC | 1000 | 87110 | COM NEW |
| MERSANA THERAPEUTICS INC | 100 | 2893 | COM |